NCT02607982 - CCRT for Esophageal Cancer. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2014

Study Completion Date

November 30, 2015

Conditions

Esophageal CancerConcurrent ChemoradiotherapyOxaliplatinPaclitaxel

Interventions

DRUG

Paclitaxel

PTX 135 mg/m2 was administered intravenously over 3 hours on Day 1 and Day 29 with standard premedications.

DRUG

Oxaliplatin

oxaliplatin (125mg/ m²) was given as a 2 hours infusion. Chemotherapy was started concurrently with radiation on day 1.

RADIATION

Radiotherapy

Radiotherapy was given concurrently on the first day of the first cycle of chemotherapy. The GTV received 60Gy (30 fractions at 2Gy per fraction) and CTV was 40 Gy (20 fractions at 2Gy per fraction). Radiotherapy was delivered in three-dimensional conformal technique (3D-CRT) and no intensity-modulated radiotherapy was used.

All Listed Sponsors

lead

Hangzhou Cancer Hospital

OTHER